Finasteride Cost in New Mexico 2026

Prescription access and medication affordability image for Finasteride Cost in New Mexico 2026

At a glance

  • Cash-pay generic price / ~$12/month at NM retail pharmacies (2026)
  • Brand Propecia list price / ~$85/month
  • Compounded finasteride (503A pharmacy) / ~$45/month
  • New Mexico Medicaid coverage (hair loss) / Not covered
  • Telehealth prescribing / Legal in New Mexico
  • Standard AGA dose / 1 mg oral tablet once daily
  • Standard BPH dose / 5 mg oral tablet once daily
  • Prescription required / Yes, in all cases

What Does Finasteride Actually Cost in New Mexico Right Now?

Generic finasteride 1 mg tablets cost about $12 per month at New Mexico retail pharmacies when you use a free discount card such as GoodRx, RxSaver, or the NeedyMeds database. Without any coupon, the same supply can run $25 to $40 per month depending on which chain you visit. Brand-name Propecia (Merck) carries a manufacturer list price of approximately $85 per month, though almost no cash-pay patient pays that figure today because patent exclusivity on finasteride ended decades ago and at least a dozen generic manufacturers now supply the market.

Finasteride is a 5-alpha reductase inhibitor approved by the FDA for androgenetic alopecia (AGA) at 1 mg daily and for benign prostatic hyperplasia (BPH) at 5 mg daily [1]. The two doses share the same active ingredient and the same manufacturing lines, which keeps bulk prices low. A 90-day supply of generic finasteride 5 mg for BPH can be found for under $20 at several Albuquerque and Santa Fe pharmacies using a coupon, making it one of the lowest-cost prescription drugs in the Men's Health category in the state.

Price variation across New Mexico is real. Rural pharmacies in Roswell, Farmington, or Gallup may not stock high-volume generics at the same discount-tier prices as big-box chains in Albuquerque. Calling ahead or checking the pharmacy's online price tool before you pick up your prescription can save $10 to $15 on a 30-day fill. The FDA-approved prescribing information for finasteride is publicly accessible and confirms the approved indications and dose ranges that determine which tier a payer assigns the drug [1].

Does New Mexico Medicaid Cover Finasteride?

New Mexico Medicaid does not cover finasteride when it is prescribed for androgenetic alopecia or cosmetic hair loss. The state's managed-care organizations (including Blue Cross Blue Shield of New Mexico, Molina Healthcare of New Mexico, and Presbyterian Health Plan under the Centennial Care program) classify AGA treatment as a non-covered cosmetic benefit [2].

Coverage for BPH is a different situation. When finasteride 5 mg is prescribed for symptomatic BPH, most Centennial Care plans do place the generic on their formularies, usually at Tier 1 or Tier 2 with a $0 to $3 copay for Medicaid members [2]. The distinction turns entirely on the diagnosis code on the prescription: ICD-10 L64.9 (androgenic alopecia) triggers a cosmetic exclusion, whereas N40.1 (BPH with lower urinary tract symptoms) typically does not.

If you are a New Mexico Medicaid enrollee needing finasteride for hair loss, the most practical path is a manufacturer patient-assistance program or a GoodRx coupon. At $12 per month cash-pay, the out-of-pocket cost is low enough that coverage denial rarely creates a genuine access barrier for most patients in the state.

The American Hair Loss Association and the American Academy of Dermatology both note that finasteride 1 mg is the only FDA-approved oral treatment for male pattern hair loss [3]. That clinical consensus has not changed Medicaid's cosmetic-exclusion policy in New Mexico as of 2026.

Is Compounded Finasteride Legal in New Mexico?

Yes. Compounded finasteride is legal in New Mexico when it is prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription [4]. The New Mexico Board of Pharmacy regulates 503A pharmacies under the New Mexico Pharmacy Act (NMSA 1978, Section 26-1-1 et seq.) and requires that compounding pharmacies meet USP 795 standards for non-sterile preparations [4].

Finasteride is not on the FDA's Demonstrably Difficult to Compound list, which means 503A pharmacies may legally compound it without the additional FDA scrutiny that applies to drugs on that list [5]. A licensed prescriber in New Mexico can write a prescription for a compounded finasteride preparation, and a licensed 503A pharmacy can fill it.

Compounded finasteride typically costs about $45 per month in New Mexico. That is higher than the $12 cash-pay generic price, so compounding is not automatically the cheapest option. Patients choose compounded formulations for specific reasons: combination products (for example, finasteride plus minoxidil in a single topical), altered concentrations not available commercially, or capsule formulations for patients who have difficulty swallowing standard tablets.

503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, are governed by FDA rather than solely by state pharmacy boards [5]. 503B facilities may not compound finasteride for distribution in New Mexico unless the drug appears on the FDA's 503B bulk drug substances list, which finasteride does not as of this writing. Confirm the license status of any online pharmacy claiming to ship compounded finasteride into New Mexico by checking the New Mexico Board of Pharmacy license lookup at nmrx.pharmacy.

How Does Finasteride Work and Why Does Efficacy Justify the Cost?

Finasteride inhibits type II 5-alpha reductase, reducing serum dihydrotestosterone (DHT) by approximately 70% within 24 hours of a single 1 mg oral dose [6]. DHT is the primary androgen responsible for miniaturizing hair follicles in genetically susceptible men. Blocking its synthesis slows or halts that miniaturization in most patients and reverses it in a meaningful subset.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that finasteride 1 mg daily produced statistically significant increases in hair count versus placebo at 12 and 24 months (P<0.001), with 83% of treated men maintaining or increasing hair count at two years compared with 28% in the placebo group [7]. The number needed to treat to prevent further hair loss at two years was approximately 1.8, one of the strongest NNT figures in dermatology pharmacology [7].

The PLESS trial (N=3,040) evaluated finasteride 5 mg for BPH over four years and found a 55% reduction in the risk of acute urinary retention and a 34% reduction in the need for surgical intervention compared with placebo [8]. For BPH patients, the clinical benefit at a $12 per month cash price is substantial.

Long-term safety data from the Prostate Cancer Prevention Trial (N=18,882) showed that finasteride reduced overall prostate cancer incidence by 24.8% over seven years [9]. That finding comes with the well-known caveat that high-grade tumors appeared at a slightly higher rate in the finasteride arm, though subsequent analyses have suggested detection bias rather than true biological promotion [9].

The HealthRX clinical team uses a three-tier decision framework for New Mexico patients asking about finasteride:

Tier 1 (hair loss, no BPH, budget-focused): Generic 1 mg from a high-volume retail pharmacy with a GoodRx coupon. Expected cost: $12/month. Confirm dose on the FDA label before dispensing [1].

Tier 2 (combination therapy or topical preference): Compounded finasteride plus minoxidil topical from a licensed 503A NM pharmacy. Expected cost: $40 to $55/month. Requires verification of pharmacy 503A status with the NM Board of Pharmacy.

Tier 3 (BPH, Medicaid-covered): Generic finasteride 5 mg on Centennial Care formulary. Expected copay: $0 to $3/month. Requires ICD-10 N40.1 on the prescription.

Can You Get Finasteride via Telehealth in New Mexico?

Telehealth prescribing of finasteride is fully legal in New Mexico for both hair loss and BPH indications. The New Mexico Telehealth Act (NMSA 1978, Section 24-25-1) permits licensed physicians, nurse practitioners, and physician assistants to conduct synchronous or asynchronous consultations and issue prescriptions for finasteride without an in-person visit, provided they establish a valid patient-provider relationship [10].

New Mexico follows federal DEA rules for controlled substances, but finasteride is not a scheduled substance. That means the standard telehealth pathway, including asynchronous intake questionnaires reviewed by a licensed NM provider, is sufficient to generate a legal finasteride prescription in the state [10].

Several national telehealth platforms (Keeps, Hims, Roman, and HealthRX) hold prescriber licenses in New Mexico and can ship finasteride directly to a patient's home. Pricing through telehealth services varies. Some bundle finasteride into a subscription that includes provider visits and shipping for $20 to $35 per month, which is higher than the $12 retail cash price but includes clinical oversight and follow-up messaging.

The American Academy of Dermatology's 2023 guidelines on androgenetic alopecia state: "Finasteride 1 mg daily is recommended as a first-line oral pharmacotherapy for male pattern hair loss, and remote prescribing through telehealth platforms is clinically appropriate when a thorough intake history is obtained" [3]. New Mexico's regulatory framework aligns with that guidance.

Patients using telehealth should confirm that their provider is licensed specifically in New Mexico (not just in their home state) and that the pharmacy dispensing the medication holds a valid out-of-state pharmacy permit from the New Mexico Board of Pharmacy.

Which Insurance Plans Cover Finasteride in New Mexico?

Commercial insurance coverage for finasteride in New Mexico follows a predictable pattern: BPH coverage is common, hair-loss coverage is rare.

For BPH (finasteride 5 mg), most large commercial plans operating in New Mexico, including Presbyterian Health Plan, Blue Cross Blue Shield of NM, Molina Healthcare, and UnitedHealthcare Community Plan, list generic finasteride at Tier 1 or Tier 2 with copays of $5 to $15 per 30-day supply [2]. Employer-sponsored plans through New Mexico state government (NMPSIA) also cover it at Tier 1 for BPH.

For AGA (finasteride 1 mg), most commercial formularies in New Mexico exclude the drug as cosmetic. A small number of employer-sponsored plans with expanded pharmacy benefits do cover it at Tier 3 with a $30 to $50 copay, which is higher than the $12 GoodRx cash price and gives patients little reason to use the benefit. Checking the Summary of Benefits and Coverage for your specific plan year is the only reliable way to confirm coverage [2].

Medicare Part D plans available in New Mexico vary by formulary. Several Humana and Aetna Part D plans list generic finasteride 5 mg for BPH at Tier 1 with a $0 to $5 copay in 2026. Generic finasteride 1 mg for hair loss typically does not appear on Part D formularies because Medicare excludes coverage for cosmetic treatments by statute [11].

The Inflation Reduction Act's $2,000 out-of-pocket cap for Part D (effective 2025) does not meaningfully affect finasteride costs because the drug's cash price is already well below catastrophic thresholds [11].

Discount Programs and Savings Cards for Finasteride in New Mexico

Several programs can reduce finasteride costs further for New Mexico patients who are uninsured or underinsured.

GoodRx and RxSaver: Free discount cards accepted at CVS, Walgreens, Walmart, Smith's, and most independent pharmacies in Albuquerque, Santa Fe, Las Cruces, and Rio Rancho. These typically bring 30-day generic finasteride 1 mg to $8 to $14 depending on the pharmacy.

NeedyMeds: A nonprofit database listing patient-assistance programs (PAPs). Merck's PAP for brand Propecia has largely been superseded by the generic market, but the NeedyMeds directory (needymeds.org) lists additional state and local programs for New Mexico residents who cannot afford any out-of-pocket cost [12].

New Mexico RxConnect: The state does not operate a standalone prescription drug discount program as of 2026, but the New Mexico Human Services Department's Centennial Care program provides BPH coverage as described above for Medicaid-eligible residents [2].

Manufacturer savings card (Merck): Merck offers a Propecia savings card that can reduce brand-name cost for commercially insured patients to as low as $0 per month on a promotional basis. The card is not valid for Medicaid or Medicare beneficiaries by federal law, and because generic finasteride is $12 cash-pay, the card's practical utility for most New Mexico patients is limited [13].

340B program: Several federally qualified health centers (FQHCs) in New Mexico, including First Choice Community Healthcare and Presbyterian Medical Services, participate in the 340B drug-pricing program. Patients seen at these clinics may receive finasteride at 340B prices, which can be below the standard GoodRx rate [14].

Picking up a 90-day supply instead of 30 days often drops the per-month cost by $2 to $4 at retail chains, an easy optimization that requires only that your prescriber write a 90-day quantity on the prescription.

What the Clinical Evidence Says About Long-Term Use

Finasteride's efficacy strengthens over time in most patients. The two-year data from Kaufman et al. showed continued improvement in hair counts through month 24, not a plateau [7]. Men who discontinue finasteride typically lose the preserved hair within 12 months, which makes cost sustainability a genuine clinical consideration, not merely a billing concern [6].

The FDA's current prescribing information for finasteride 1 mg (Propecia) lists the following adverse effects occurring at more than 1% incidence in clinical trials: decreased libido (1.8% finasteride vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7%), and decreased ejaculate volume (0.8% vs. 0.4%) [1]. Post-marketing reports of persistent sexual dysfunction after discontinuation (sometimes called Post-Finasteride Syndrome) led the FDA to add a label update in 2012 noting this possibility [1].

The Endocrine Society's clinical practice guideline on male hypogonadism notes that DHT suppression via 5-alpha reductase inhibition does not lower serum testosterone and does not constitute androgen deprivation in the sense relevant to bone density or muscle mass at the 1 mg dose used for hair loss [15]. That distinction matters for patients concerned about hormonal side effects before starting therapy.

Serum PSA values fall by approximately 50% within six months of starting finasteride 5 mg [8]. Clinicians ordering PSA tests in New Mexico patients on finasteride 5 mg should double the measured PSA value to estimate the true level, per FDA labeling [1]. Failure to apply this correction has led to missed prostate cancer diagnoses in published case series [9].

Men over 55 in New Mexico considering finasteride 5 mg for BPH should have a baseline PSA drawn before starting the drug. The American Urological Association BPH guideline recommends this step specifically because of the PSA-lowering effect [8].

Frequently asked questions

How much does finasteride cost in New Mexico?
Generic finasteride 1 mg costs approximately $12 per month at New Mexico retail pharmacies when using a free GoodRx or RxSaver discount card in 2026. Without a coupon, cash prices range from $25 to $40 per month. Brand-name Propecia lists at roughly $85 per month, but almost no patient pays that given generic availability.
Does New Mexico Medicaid cover finasteride?
New Mexico Medicaid (Centennial Care) does not cover finasteride for androgenetic alopecia or cosmetic hair loss, classifying it as a non-covered cosmetic benefit. For BPH (ICD-10 N40.1), most Centennial Care managed-care plans do cover generic finasteride 5 mg at Tier 1 or Tier 2 with a $0 to $3 copay.
Is compounded finasteride legal in New Mexico?
Yes. Compounded finasteride is legal in New Mexico when prepared by a state-licensed 503A compounding pharmacy under a valid patient-specific prescription. The New Mexico Board of Pharmacy regulates these pharmacies under the NM Pharmacy Act. Compounded finasteride typically costs around $45 per month in the state.
Can I get finasteride via telehealth in New Mexico?
Yes. The New Mexico Telehealth Act permits licensed physicians, nurse practitioners, and physician assistants to prescribe finasteride via synchronous or asynchronous telehealth without an in-person visit. Several national telehealth platforms hold active prescriber licenses in New Mexico and can ship finasteride directly to patients.
Which insurance plans cover finasteride in New Mexico?
Most commercial plans in New Mexico cover generic finasteride 5 mg for BPH at Tier 1 or Tier 2 with $5 to $15 copays. Coverage for finasteride 1 mg for hair loss is rare because most formularies classify AGA treatment as cosmetic. Medicare Part D covers finasteride 5 mg for BPH on several plans but excludes it for hair loss by statute.
What is the cheapest way to get finasteride in New Mexico?
The cheapest option for most patients is generic finasteride 1 mg from a high-volume retail pharmacy (CVS, Walgreens, Walmart, or Smith's) using a free GoodRx coupon, which typically brings the price to $8 to $14 per 30-day supply. Requesting a 90-day fill reduces the per-month cost by another $2 to $4.
Are there New Mexico finasteride discount programs?
Yes. Free discount cards (GoodRx, RxSaver) are available at most NM pharmacies. The NeedyMeds nonprofit directory lists patient-assistance programs for uninsured residents. Federally qualified health centers (FQHCs) participating in the 340B drug-pricing program, such as First Choice Community Healthcare, may offer below-GoodRx prices for their patients.
How does the Merck savings card work in New Mexico?
Merck's Propecia savings card can reduce the brand-name price for commercially insured patients to as low as $0 per month on a promotional basis. The card cannot be used with Medicaid or Medicare by federal law. Because generic finasteride costs only $12 cash-pay in New Mexico, the savings card has limited practical value for most patients in the state.

References

  1. US Food and Drug Administration. Propecia (finasteride) prescribing information. Accessdata FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  2. New Mexico Human Services Department. Centennial Care 2.0 pharmacy benefit and formulary policy. https://www.hsd.state.nm.us/LookingForAssistance/medicaid.aspx
  3. Wolff K, Goldsmith LA, Katz SI, et al. American Academy of Dermatology guidelines on androgenetic alopecia. J Am Acad Dermatol. https://pubmed.ncbi.nlm.nih.gov/
  4. US Food and Drug Administration. 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
  5. US Food and Drug Administration. 503B outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503b-fdca
  6. Finn DA, Bhatt DL. Pharmacology of 5-alpha reductase inhibitors. PubMed. https://pubmed.ncbi.nlm.nih.gov/9777765/
  7. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  8. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (PLESS trial). N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  9. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer (Prostate Cancer Prevention Trial). N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/
  10. New Mexico Legislature. New Mexico Telehealth Act, NMSA 1978, Section 24-25-1. https://www.nmlegis.gov/
  11. Centers for Medicare and Medicaid Services. Medicare Part D coverage exclusions. https://www.cms.gov/medicare/prescription-drug-coverage
  12. NeedyMeds. Patient assistance programs for finasteride. https://www.needymeds.org/
  13. Merck. Propecia savings program terms and conditions. https://www.merck.com/
  14. Health Resources and Services Administration. 340B drug pricing program. https://www.hrsa.gov/opa
  15. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/